MARKET

ROIV

ROIV

Roivant Sciences
NASDAQ
34.07
+0.05
+0.15%
After Hours: 34.07 0 0.00% 17:25 06/26 EDT
OPEN
34.06
PREV CLOSE
34.02
HIGH
34.45
LOW
33.72
VOLUME
12.41M
TURNOVER
--
52 WEEK HIGH
34.68
52 WEEK LOW
10.71
MARKET CAP
24.51B
P/E (TTM)
-78.8657
1D
5D
1M
3M
1Y
5Y
1D
Top Biotech Executive Makes Bold Move With Major Roivant Stock Sale
TipRanks · 1d ago
Immunovant director Atul Pande disposes of 1,500 common shares for $57,015
PUBT · 1d ago
Roivant Sciences President and Immunovant CEO Eric Venker disposes of common shares worth $6.63 million
PUBT · 1d ago
Argenx Analyst Is Bullish Despite Changes To Phase 3 Myositis Study
Benzinga · 2d ago
Weekly Report: what happened at ROIV last week (0615-0619)?
Weekly Report · 6d ago
What Roivant Sciences (ROIV)'s $2.25 Billion Moderna Settlement and Immunology Wins Mean For Shareholders
Simply Wall St · 06/20 16:26
Roivant Sciences (ROIV) Stock Could Be 19.5% Undervalued After Moderna Settlement And Pipeline Progress
Simply Wall St · 06/19 11:21
Analysts’ Opinions Are Mixed on These Healthcare Stocks: enGene Holdings (ENGN), Medtronic (MDT) and Roivant Sciences (ROIV)
TipRanks · 06/16 11:01
More
About ROIV
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Webull offers Roivant Sciences Ltd stock information, including NASDAQ: ROIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ROIV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ROIV stock methods without spending real money on the virtual paper trading platform.